SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Akers Biosciences, Inc. – ‘8-K’ for 10/11/18 – ‘EX-10.1’

On:  Thursday, 10/11/18, at 4:30pm ET   ·   For:  10/11/18   ·   Accession #:  1493152-18-14374   ·   File #:  1-36268

Previous ‘8-K’:  ‘8-K’ on / for 9/11/18   ·   Next:  ‘8-K/A’ on 10/12/18 for 10/11/18   ·   Latest:  ‘8-K’ on 4/18/24 for 4/15/24   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/11/18  Akers Biosciences, Inc.           8-K:5,8,9  10/11/18    4:4.6M                                   M2 Compliance/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     29K 
 2: EX-10.1     Material Contract                                   HTML     10K 
 3: EX-10.2     Material Contract                                   HTML      5K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     17K 


EX-10.1   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 10.1

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 

 

 C: 
   
 

 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  MyMD Pharmaceuticals, Inc.        10-K       12/31/23   71:11M                                    M2 Compliance LLC/FA
 3/31/23  MyMD Pharmaceuticals, Inc.        10-K       12/31/22   77:10M                                    M2 Compliance LLC/FA
 3/31/22  MyMD Pharmaceuticals, Inc.        10-K       12/31/21   77:11M                                    M2 Compliance LLC/FA
 3/19/21  MyMD Pharmaceuticals, Inc.        S-4/A                121:17M                                    M2 Compliance LLC/FA
 3/01/21  MyMD Pharmaceuticals, Inc.        10-K       12/31/20   69:7.8M                                   M2 Compliance LLC/FA
 1/15/21  MyMD Pharmaceuticals, Inc.        S-4                    6:9.5M                                   M2 Compliance LLC/FA
10/21/20  MyMD Pharmaceuticals, Inc.        10-K/A     12/31/19    6:1.1M                                   M2 Compliance LLC/FA
Top
Filing Submission 0001493152-18-014374   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:40:52.1am ET